Try the modernized ClinicalTrials.gov beta website. Learn more about the modernization effort.
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Feasibility in France of a Mindfulness-based Group Therapy for Adolescents With Chronic Pain (PEACEFULL)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03561077
Recruitment Status : Recruiting
First Posted : June 19, 2018
Last Update Posted : August 25, 2020
Sponsor:
Information provided by (Responsible Party):
University Hospital, Toulouse

Brief Summary:
The main objective is to study the feasibility of a program for the management of chronic painful adolescents in meditation groups. This program is an adaptation of the MBI-A (Mindfulness-based intervention for adolescent) program developed in another socio-cultural context (i.e. in Canada). The secondary objectives will be to study the effect of a mindfulness meditation program for adolescents on pain, quality of life, acceptance of pain, functional disability, catastrophism, anxiety-depression, emotional repercussions and acceptance of mindfulness

Condition or disease Intervention/treatment Phase
Chronic Pain Other: Mindfulness-based interventions (MBI's) Not Applicable

Detailed Description:

Paediatric chronic pain can lead to serious consequences in terms of daily functioning (school absenteeism and loss of social interactions) and global quality of life. Mindfulness-based interventions (MBI's) approaches which emphasize acceptance rather than control of pain have gained increasing attention in adults with chronic pain. The effectiveness of MBI's for chronic pain in paediatric population remains largely unknown. An MBI program for adolescent was conducted in Toronto's Hospital for Sick Children and happened to be feasible and well received for adolescents with chronic pain conditions. The aim of the present program is to study the feasibility in France of a mindfulness program dedicated for adolescents with chronic pain.

An eight-session, two hour Mindfulness Based Intervention dedicated to adolescents will be provided. The intervention will focus on skill building and will incorporate mindfulness meditation, exercises and activities specially adapted to teenagers with chronic pain. Topics will include mind body connection, the effect of stress on pain, living in the present moment, focused awareness, responding versus reacting to pain and/ or difficult situations, non judgement, gratitude, kindness and compassion towards self and others.

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 25 participants
Allocation: N/A
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Other
Official Title: Feasibility in France of a Mindfulness-based Group Therapy for Adolescents With Chronic Pain
Actual Study Start Date : May 2, 2018
Estimated Primary Completion Date : October 2021
Estimated Study Completion Date : October 2021

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Chronic Pain

Arm Intervention/treatment
Experimental: Mindfulness program
To study the feasibility in France of a mindfulness program with mindfulness-based interventions (MBI's) dedicated for adolescents with chronic pain.
Other: Mindfulness-based interventions (MBI's)
Mindfulness Based Intervention with eight sessions (one session per week) of two hours dedicated to adolescents will be provided. The intervention will focus on skill building and will incorporate mindfulness meditation, exercises and activities specially adapted to teenagers with chronic pain. Topics will include mind body connection, the effect of stress on pain, living in the present moment, focused awareness, responding versus reacting to pain and/ or difficult situations, non judgement, gratitude, kindness and compassion towards self and others.




Primary Outcome Measures :
  1. Feasibility in France of a mindfulness program : percentage of adolescents who will attend at least 6 of the 8 sessions [ Time Frame: End of the mindfulness program (8 weeks) ]
    The primary outcome will be the percentage of adolescents who will attend at least 6 of the 8 sessions.


Secondary Outcome Measures :
  1. Attendance rate [ Time Frame: 1st session of the program (T1 week) ]
    Percentage of adolescents present at each program session

  2. Attendance rate [ Time Frame: 2nd session of the program (T2 weeks) ]
    Percentage of adolescents present at each program session

  3. Attendance rate [ Time Frame: 3rd session of the program (T3 weeks) ]
    Percentage of adolescents present at each program session

  4. Attendance rate [ Time Frame: 4th session of the program (T4 weeks) ]
    Percentage of adolescents present at each program session

  5. Attendance rate [ Time Frame: 5th session of the program (T5 weeks) ]
    Percentage of adolescents present at each program session

  6. Attendance rate [ Time Frame: 6th session of the program (T6 weeks) ]
    Percentage of adolescents present at each program session

  7. Attendance rate [ Time Frame: 7th session of the program (T7 weeks) ]
    Percentage of adolescents present at each program session

  8. Attendance rate [ Time Frame: 8th session of the program (T8 weeks) ]
    Percentage of adolescents present at each program session

  9. Punctuality at the session [ Time Frame: 1st session of the program (T1 week) ]
    binary criterion yes/no

  10. Punctuality at the session [ Time Frame: 2nd session of the program (T2 weeks) ]
    binary criterion yes/no

  11. Punctuality at the session [ Time Frame: 3rd session of the program (T3 weeks) ]
    binary criterion yes/no

  12. Punctuality at the session [ Time Frame: 4th session of the program (T4 weeks) ]
    binary criterion yes/no

  13. Punctuality at the session [ Time Frame: 5th session of the program (T5 weeks) ]
    binary criterion yes/no

  14. Punctuality at the session [ Time Frame: 6th session of the program (T6 weeks) ]
    binary criterion yes/no

  15. Punctuality at the session [ Time Frame: 7th session of the program (T7 weeks) ]
    binary criterion yes/no

  16. Punctuality at the session [ Time Frame: 8th session of the program (T8 weeks) ]
    binary criterion yes/no

  17. Treatment acceptability [ Time Frame: inclusion visit ]
    Rate of eligible adolescents who agreed to participate in the study

  18. Treatment acceptability [ Time Frame: 2nd session of the program (T2 weeks) ]
    Daily practice at home (binary criterion yes/no)

  19. Treatment acceptability [ Time Frame: 3rd session of the program (T3 weeks) ]
    Daily practice at home (binary criterion yes/no)

  20. Treatment acceptability [ Time Frame: 4th session of the program (T4 weeks) ]
    Daily practice at home (binary criterion yes/no)

  21. Treatment acceptability [ Time Frame: 5th session of the program (T5 weeks) ]
    Daily practice at home (binary criterion yes/no)

  22. Treatment acceptability [ Time Frame: 6th session of the program (T6 weeks) ]
    Daily practice at home (binary criterion yes/no)

  23. Treatment acceptability [ Time Frame: 7th session of the program (T7 weeks) ]
    Daily practice at home (binary criterion yes/no)

  24. Treatment acceptability [ Time Frame: 8th session of the program (T8 weeks) ]
    Daily practice at home (binary criterion yes/no)

  25. Pain Level [ Time Frame: Inclusion visit (baseline) ]
    Pain level will be assessed using Visual Analog Scale (from 0 "no pain" to 10 "the worst pain possible "). The pain will be measured by the average of the visual analogue rating scales evaluated over the last 8 days.

  26. Pain Level [ Time Frame: T2 Visit (1 week after the end of the 8-week program) ]
    Pain level will be assessed using Visual Analog Scale (from 0 "no pain" to 10 "the worst pain possible "). The pain will be measured by the average of the visual analogue rating scales evaluated over the last 8 days.

  27. Pain Level [ Time Frame: T3 Visit (3 months after the end of the 8-week program) ]
    Pain level will be assessed using Visual Analog Scale (from 0 "no pain" to 10 "the worst pain possible "). The pain will be measured by the average of the visual analogue rating scales evaluated over the last 8 days.

  28. Quality of life at baseline : impact of adolescents health on their everyday life. [ Time Frame: Inclusion visit (baseline) ]
    Quality of life will be assessed using the french scale VSPA-12 ("Vécu et Santé Perçue de l'adolescent - 12 items", "Lived and Health Perceived in 12 items) which is a self-questionnaire to assess the impact of adolescents health on their everyday life. The 12 items have five possible answers: never, rarely, sometimes, often, always.

  29. Quality of life at the end of program [ Time Frame: T2 Visit (1 week after the end of the 8-week program) ]
    Quality of life will be assessed using the french scale VSPA-12 ("Vécu et Santé Perçue de l'adolescent - 12 items", "Lived and Health Perceived in 12 items) which is a self-questionnaire to assess the impact of adolescents health on their everyday life. The 12 items have five possible answers: never, rarely, sometimes, often, always.

  30. Quality of life in long term [ Time Frame: T3 Visit (3 months after the end of the 8-week program) ]
    Quality of life will be assessed using the french scale VSPA-12 ("Vécu et Santé Perçue de l'adolescent - 12 items", "Lived and Health Perceived in 12 items) which is a self-questionnaire to assess the impact of adolescents health on their everyday life. The 12 items have five possible answers: never, rarely, sometimes, often, always.

  31. Chronic pain acceptance [ Time Frame: Inclusion visit (baseline) ]
    Chronic pain acceptance will be assessed using CPAQ-A (Chronic Pain Acceptance Questionnaire, Adolescent version) translated in French. CPAQ-A (Questionnaire for acceptance of chronic pain for adolescents) has 20 items For each item, the answer modalities are: 0= Never True, 1 = Rarely true, 2 = sometimes true, 3 = Often true, 4 = always true.

  32. Chronic pain acceptance [ Time Frame: T2 Visit (1 week after the end of the 8-week program) ]
    Chronic pain acceptance will be assessed using CPAQ-A (Chronic Pain Acceptance Questionnaire, Adolescent version) translated in French. CPAQ-A (Questionnaire for acceptance of chronic pain for adolescents) has 20 items For each item, the answer modalities are: 0= Never True, 1 = Rarely true, 2 = sometimes true, 3 = Often true, 4 = always true.

  33. Chronic pain acceptance [ Time Frame: T3 Visit (3 months after the end of the 8-week program) ]
    Chronic pain acceptance will be assessed using CPAQ-A (Chronic Pain Acceptance Questionnaire, Adolescent version) translated in French. CPAQ-A (Questionnaire for acceptance of chronic pain for adolescents) has 20 items For each item, the answer modalities are: 0= Never True, 1 = Rarely true, 2 = sometimes true, 3 = Often true, 4 = always true.

  34. Functional disability [ Time Frame: Inclusion visit (baseline) ]
    Functional disability will be assessed using FDI (Functional Disability Inventory) which is a functional disability scale to assess physical problems or any difficulties that adolescents may have in performing activities of daily living. FDI have 15 items. For each item, the answer modalities are 0 = no trouble, 1 = a little trouble, 2 = some trouble, 3 = a lot of trouble and 4 = impossible. The total FDI score is a sum of all of the items. The FDI score ranges from 0 to 60, with higher score indicating greater functional disability.

  35. Functional disability [ Time Frame: T2 Visit (1 week after the end of the 8-week program) ]
    Functional disability will be assessed using FDI (Functional Disability Inventory) which is a functional disability scale to assess physical problems or any difficulties that adolescents may have in performing activities of daily living. FDI have 15 items. For each item, the answer modalities are 0 = no trouble, 1 = a little trouble, 2 = some trouble, 3 = a lot of trouble and 4 = impossible. The total FDI score is a sum of all of the items. The FDI score ranges from 0 to 60, with higher score indicating greater functional disability.

  36. Functional disability [ Time Frame: T3 Visit (3 months after the end of the 8-week program) ]
    Functional disability will be assessed using FDI (Functional Disability Inventory) which is a functional disability scale to assess physical problems or any difficulties that adolescents may have in performing activities of daily living. FDI have 15 items. For each item, the answer modalities are 0 = no trouble, 1 = a little trouble, 2 = some trouble, 3 = a lot of trouble and 4 = impossible. The total FDI score is a sum of all of the items. The FDI score ranges from 0 to 60, with higher score indicating greater functional disability.

  37. Anxiety and Depression [ Time Frame: Inclusion visit (baseline) ]
    The anxiety and depression will be assessed using the french version of the Revised Children's Anxiety and Depression Scale (RCADS) intended to evaluate the symptomatology associated with anxiety disorders and major depression in children. This scale have 29 items. For each item, the possible answers are: never, sometimes, often, always.

  38. Anxiety and Depression [ Time Frame: T2 Visit (1 week after the end of the 8-week program) ]
    The anxiety and depression will be assessed using the french version of the Revised Children's Anxiety and Depression Scale (RCADS) intended to evaluate the symptomatology associated with anxiety disorders and major depression in children. This scale have 29 items. For each item, the possible answers are: never, sometimes, often, always.

  39. Anxiety and Depression [ Time Frame: T3 Visit (3 months after the end of the 8-week program) ]
    The anxiety and depression will be assessed using the french version of the Revised Children's Anxiety and Depression Scale (RCADS) intended to evaluate the symptomatology associated with anxiety disorders and major depression in children. This scale have 29 items. For each item, the possible answers are: never, sometimes, often, always.

  40. Catastrophism [ Time Frame: Inclusion visit (baseline) ]
    Catastrophism will be assessed using PCS-Ado (Pain Catastrophizing Scale for Francophone Adolescents) which identifies the thoughts and emotions that may be associated with the pain. PCS-Ado have 13 items. For each item, the possible answers are: never, rarely, sometimes, often and always.

  41. Catastrophism [ Time Frame: T2 Visit (1 week after the end of the 8-week program) ]
    Catastrophism will be assessed using PCS-Ado (Pain Catastrophizing Scale for Francophone Adolescents) which identifies the thoughts and emotions that may be associated with the pain. PCS-Ado have 13 items. For each item, the possible answers are: never, rarely, sometimes, often and always.

  42. Catastrophism [ Time Frame: T3 Visit (3 months after the end of the 8-week program) ]
    Catastrophism will be assessed using PCS-Ado (Pain Catastrophizing Scale for Francophone Adolescents) which identifies the thoughts and emotions that may be associated with the pain. PCS-Ado have 13 items. For each item, the possible answers are: never, rarely, sometimes, often and always.

  43. Mindfulness acceptance [ Time Frame: Inclusion visit (baseline) ]
    Mindfulness acceptance will be assessed using the French version of Five Facets Mindfulness Questionnaire (FFMQ) with 39 items. For each item the possible answers are: 1 = never or very rarely true, 2 = rarely true, 3 = sometimes true, 4 = often true, 5 = very often or always true.

  44. Mindfulness acceptance [ Time Frame: T2 Visit (1 week after the end of the 8-week program) ]
    Mindfulness acceptance will be assessed using the French version of Five Facets Mindfulness Questionnaire (FFMQ) with 39 items. For each item the possible answers are: 1 = never or very rarely true, 2 = rarely true, 3 = sometimes true, 4 = often true, 5 = very often or always true.

  45. Mindfulness acceptance [ Time Frame: T3 Visit (3 months after the end of the 8-week program) ]
    Mindfulness acceptance will be assessed using the French version of Five Facets Mindfulness Questionnaire (FFMQ) with 39 items. For each item the possible answers are: 1 = never or very rarely true, 2 = rarely true, 3 = sometimes true, 4 = often true, 5 = very often or always true.

  46. Strengths and Difficulties [ Time Frame: Inclusion visit (baseline) ]
    Strengths and difficulties will be assessed using the french version of the Strengths and Difficulties Questionnaire (SDQ-Fra) with 25 items. For each item, the possible answers are : not true, a little true, very true. The total difficulty score of the SDQ ranges from 0-40.

  47. Strengths and Difficulties [ Time Frame: T2 Visit (1 week after the end of the 8-week program) ]
    Strengths and difficulties will be assessed using the french version of the Strengths and Difficulties Questionnaire (SDQ-Fra) with 25 items. For each item, the possible answers are : not true, a little true, very true. The total difficulty score of the SDQ ranges from 0-40.

  48. Strengths and Difficulties [ Time Frame: T3 Visit (3 months after the end of the 8-week program) ]
    Strengths and difficulties will be assessed using the french version of the Strengths and Difficulties Questionnaire (SDQ-Fra) with 25 items. For each item, the possible answers are : not true, a little true, very true. The total difficulty score of the SDQ ranges from 0-40.

  49. Adolescents satisfaction [ Time Frame: T2 Visit (1 week after the end of the 8-week program) ]
    Adolescents satisfaction about the mindfulness program will be assessed using a satisfaction questionnaire with 8 items designed for this study. For each item, the modality answers are scored from 1 to 4.

  50. Parents satisfaction [ Time Frame: T2 Visit (1 week after the end of the 8-week program) ]
    Parents satisfaction about the mindfulness program followed by their children will be assessed using a satisfaction questionnaire with 8 items designed for the study.



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   12 Years to 17 Years   (Child)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Teenagers from 12 to 17 years of age followed at the Children's Hospital of Toulouse, as part of the Multidisciplinary Consultation of Pain
  • including French.
  • With the consent of the teenager and the parents
  • Affiliated person or beneficiary of a social security scheme.

Exclusion Criteria:

  • intellectual deficit not allowing to participate in a meditation program
  • participating in research involving body therapies

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03561077


Contacts
Layout table for location contacts
Contact: Agnès SUC, MD 5 34 55 86 61 ext 33 suc.a@chu-toulouse.fr
Contact: Stéphanie IANUZZI, PhD IANNUZZI.S@chu-toulouse.fr

Locations
Layout table for location information
France
Hôpital des Enfants Recruiting
Toulouse, France, 31059
Contact: Agnès SUC, MD         
Sponsors and Collaborators
University Hospital, Toulouse
Investigators
Layout table for investigator information
Principal Investigator: Agnès SUC, MD University Hospital, Toulouse
Publications:

Layout table for additonal information
Responsible Party: University Hospital, Toulouse
ClinicalTrials.gov Identifier: NCT03561077    
Other Study ID Numbers: RC31/17/0354
2017-A03338-45 ( Other Identifier: ID-RCB )
First Posted: June 19, 2018    Key Record Dates
Last Update Posted: August 25, 2020
Last Verified: August 2020
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Keywords provided by University Hospital, Toulouse:
Pain
Pediatrics
Mindfulness
Adolescents
Additional relevant MeSH terms:
Layout table for MeSH terms
Chronic Pain
Pain
Neurologic Manifestations